David Lam's most recent trade in Quince Therapeutics Inc was a trade of 27,000 Director Stock Option (Right to Buy) done . Disclosure was reported to the exchange on June 4, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Quince Therapeutics Inc | David A. Lamond | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Jun 2025 | 27,000 | 27,000 | - | - | Director Stock Option (Right to Buy) | |
| Nuveen Floating Rate Incom... | David J. Lamb | Vice President | 25 Feb 2025 | 13,631 | 22,338 (0%) | 0% | 8.2 | 111,774 | Common Stock | |
| Nuveen Floating Rate Incom... | David J. Lamb | Vice President | 25 Feb 2025 | 8,707 | 0 | - | - | Subscription Right (right to buy) | ||
| Nuveen S&P 500 Buy-Write I... | David J. Lamb | Vice President | Sale of securities on an exchange or to another person at price $ 14.20 per share. | 20 Feb 2025 | 3,000 | 806 (0%) | 0% | 14.2 | 42,600 | Common Stock |
| Quince Therapeutics Inc | David A. Lamond | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Jan 2025 | 47,587 | 47,587 | - | - | Director Stock Option (right to buy) | |
| Riverview Bancorp, Inc. | David Lam | EVP/CFO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Dec 2024 | 6,721 | 77,359 (0%) | 0% | 0 | Common Stock | |
| Riverview Bancorp, Inc. | David Lam | EVP/CFO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Dec 2024 | 2,240 | 70,638 (0%) | 0% | 0 | Common Stock | |
| CVR Energy Inc | Lamp David L. | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Dec 2024 | 86,842 | 86,842 | - | - | Incentive Units | |
| CVR Energy Inc | Lamp L. David | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 11 Dec 2024 | 24,177 | 24,177 (0%) | 0% | 0 | Common Stock | |
| CVR Energy Inc | Lamp David L. | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 11 Dec 2024 | 24,177 | 0 | - | - | Incentive Units | |
| CVR Energy Inc | Lamp L. David | Director, President and CEO | Sale or transfer of securities back to the company at price $ 19.09 per share. | 11 Dec 2024 | 24,177 | 0 (0%) | 0% | 19.1 | 461,539 | Common Stock |
| CVR Energy Inc | L. David Lamp | Director, President and CEO | Sale or transfer of securities back to the company at price $ 19.09 per share. | 11 Dec 2024 | 17,389 | 0 (0%) | 0% | 19.1 | 331,956 | Common Stock |
| CVR Energy Inc | L. David Lamp | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 11 Dec 2024 | 17,389 | 17,389 (0%) | 0% | 0 | Common Stock | |
| CVR Energy Inc | David Lamp L. | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 11 Dec 2024 | 17,389 | 34,776 | - | - | Incentive Units | |
| CVR Energy Inc | David Lamp L. | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 11 Dec 2024 | 13,963 | 13,963 (0%) | 0% | 0 | Common Stock | |
| CVR Energy Inc | L. Lamp David | Director, President and CEO | Sale or transfer of securities back to the company at price $ 19.09 per share. | 11 Dec 2024 | 13,963 | 0 (0%) | 0% | 19.1 | 266,554 | Common Stock |
| CVR Energy Inc | David Lamp L. | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 11 Dec 2024 | 13,963 | 13,962 | - | - | Incentive Units | |
| Nuveen AMT-Free Municipal ... | David J. Lamb | Vice President | Purchase of securities on an exchange or from another person at price $ 12.44 per share. | 06 Nov 2024 | 3,000 | 3,000 (0%) | 0% | 12.4 | 37,320 | Common Stock |
| Quince Therapeutics Inc | David A. Lamond | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Jun 2024 | 27,000 | 27,000 | - | - | Employee Stock Option (right to buy) | |
| Nuveen AMT-Free Quality Mu... | David J. Lamb | Vice President | Purchase of securities on an exchange or from another person at price $ 11.04 per share. | 27 Mar 2024 | 6,000 | 6,000 (0%) | 0% | 11.0 | 66,240 | Common Stock |
| Distribution Solutions Gro... | David S. Lambert | VP, Controller and CAO | Grant, award, or other acquisition of securities at price $ 30.65 per share. | 08 Mar 2024 | 1,301 | 2,603 (0%) | 0% | 30.7 | 39,876 | Common Stock |
| Distribution Solutions Gro... | David S. Lambert | VP, Controller and CAO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 30.65 per share. | 08 Mar 2024 | 481 | 2,122 (0%) | 0% | 30.7 | 14,743 | Common Stock |
| Distribution Solutions Gro... | David S. Lambert | VP, Controller and CAO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 31 Dec 2023 | 598 | 0 | - | - | Restricted Stock Units | |
| Distribution Solutions Gro... | David S. Lambert | VP, Controller and CAO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 31.56 per share. | 31 Dec 2023 | 598 | 1,900 (0%) | 0% | 31.6 | 18,873 | Common Stock |
| Distribution Solutions Gro... | David S. Lambert | VP, Controller and CAO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 31.56 per share. | 31 Dec 2023 | 211 | 1,689 (0%) | 0% | 31.6 | 6,659 | Common Stock |
| CVR Energy Inc | Lamp L. David | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Dec 2023 | 52,165 | 52,165 | - | - | Incentive Units | |
| CVR Energy Inc | Lamp L. David | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 13 Dec 2023 | 44,722 | 0 | - | - | Incentive Units | |
| CVR Energy Inc | L. Lamp David | Director, President and CEO | Sale or transfer of securities back to the company at price $ 30.97 per share. | 13 Dec 2023 | 44,722 | 0 (0%) | 0% | 31.0 | 1,385,040 | Common Stock |
| CVR Energy Inc | L. Lamp David | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 13 Dec 2023 | 44,722 | 44,722 (0%) | 0% | 0 | Common Stock | |
| CVR Energy Inc | Lamp L. David | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 13 Dec 2023 | 24,178 | 24,178 (0%) | 0% | 0 | Common Stock | |
| CVR Energy Inc | David Lamp L. | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 13 Dec 2023 | 24,178 | 24,177 | - | - | Incentive Units | |
| CVR Energy Inc | David Lamp L. | Director, President and CEO | Sale or transfer of securities back to the company at price $ 30.97 per share. | 13 Dec 2023 | 24,178 | 0 (0%) | 0% | 31.0 | 748,793 | Common Stock |
| CVR Energy Inc | David Lamp L. | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 13 Dec 2023 | 13,963 | 27,925 | - | - | Incentive Units | |
| CVR Energy Inc | David Lamp L. | Director, President and CEO | Sale or transfer of securities back to the company at price $ 30.97 per share. | 13 Dec 2023 | 13,963 | 0 (0%) | 0% | 31.0 | 432,434 | Common Stock |
| CVR Energy Inc | Lamp David L. | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 13 Dec 2023 | 13,963 | 13,963 (0%) | 0% | 0 | Common Stock | |
| Quince Therapeutics Inc | David Lamond A. | Director | Purchase of securities on an exchange or from another person at price $ 1.04 per share. | 12 Dec 2023 | 22,627 | 2,347,545 (7%) | 0% | 1.0 | 23,532 | Common Stock |
| Quince Therapeutics Inc | A. David Lamond | Director | Purchase of securities on an exchange or from another person at price $ 1.00 per share. | 12 Dec 2023 | 22,627 | 2,324,918 (7%) | 0% | 1 | 22,627 | Common Stock |
| Quince Therapeutics Inc | A. David Lamond | Director | Purchase of securities on an exchange or from another person at price $ 1.02 per share. | 12 Dec 2023 | 22,327 | 2,302,291 (7%) | 0% | 1.0 | 22,774 | Common Stock |
| Quince Therapeutics Inc | A. Lamond David | Director | Purchase of securities on an exchange or from another person at price $ 1.00 per share. | 12 Dec 2023 | 300 | 2,279,964 (7%) | 0% | 1 | 300 | Common Stock |
| Quince Therapeutics Inc | David Lamond A. | Director | Purchase of securities on an exchange or from another person at price $ 1.02 per share. | 05 Dec 2023 | 19,123 | 2,260,541 (7%) | 0% | 1.0 | 19,505 | Common Stock |
| Quince Therapeutics Inc | Lamond A. David | Director | Purchase of securities on an exchange or from another person at price $ 1.01 per share. | 05 Dec 2023 | 19,123 | 2,279,664 (7%) | 0% | 1.0 | 19,314 | Common Stock |
| Quince Therapeutics Inc | A. Lamond David | Director | Purchase of securities on an exchange or from another person at price $ 1.01 per share. | 05 Dec 2023 | 19,123 | 2,241,418 (7%) | 0% | 1.0 | 19,314 | Common Stock |
| Quince Therapeutics Inc | David A. Lamond | Director | Purchase of securities on an exchange or from another person at price $ 1.32 per share. | 30 Aug 2023 | 41,026 | 2,179,161 (7%) | 0% | 1.3 | 54,154 | Common Stock |
| Quince Therapeutics Inc | David A. Lamond | Director | Purchase of securities on an exchange or from another person at price $ 1.31 per share. | 30 Aug 2023 | 41,026 | 2,138,135 (7%) | 0% | 1.3 | 53,744 | Common Stock |
| Quince Therapeutics Inc | David A. Lamond | Director | Purchase of securities on an exchange or from another person at price $ 1.29 per share. | 15 Aug 2023 | 117,348 | 2,072,343 (7%) | 0% | 1.3 | 151,379 | Common Stock |
| Quince Therapeutics Inc | David A. Lamond | Director | Purchase of securities on an exchange or from another person at price $ 1.32 per share. | 15 Aug 2023 | 107,886 | 1,954,995 (6%) | 0% | 1.3 | 142,410 | Common Stock |
| Quince Therapeutics Inc | David A. Lamond | Director | Purchase of securities on an exchange or from another person at price $ 1.29 per share. | 15 Aug 2023 | 24,766 | 2,097,109 (7%) | 0% | 1.3 | 31,948 | Common Stock |
| Nuveen Floating Rate Incom... | David J. Lamb | Vice President | Other type of transaction at price $ 0.00 per share. | 31 Jul 2023 | 4,707 | 4,707 | - | 0 | Class A Common Stock | |
| Riverview Bancorp, Inc. | David Lam | EVP/CFO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Jul 2023 | 7,145 | 66,829 (0%) | 0% | 0 | Common Stock | |
| Riverview Bancorp, Inc. | David Lam | EVP/CFO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Jul 2023 | 2,382 | 59,684 (0%) | 0% | 0 | Common Stock | |
| Nuveen Municipal Credit In... | David J. Lamb | Vice President | Purchase of securities on an exchange or from another person at price $ 11.48 per share. | 06 Jul 2023 | 5,000 | 11,000 (0%) | 0% | 11.5 | 57,400 | Common Stock |
| Riverview Bancorp, Inc. | David Lam | EVP/CFO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 2.78 per share. | 29 Jun 2023 | 1,511 | 52,480 (0%) | 0% | 2.8 | 4,201 | Common Stock |
| Distribution Solutions Gro... | David S. Lambert | VP, Controller and CAO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Jun 2023 | 1,000 | 0 | - | - | Restricted Stock Units | |
| Distribution Solutions Gro... | David S. Lambert | VP, Controller and CAO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 52.48 per share. | 15 Jun 2023 | 1,000 | 1,655 (0%) | 0% | 52.5 | 52,480 | Common Stock |
| Distribution Solutions Gro... | David S. Lambert | VP, Controller and CAO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 52.48 per share. | 15 Jun 2023 | 353 | 1,302 (0%) | 0% | 52.5 | 18,525 | Common Stock |
| Quince Therapeutics Inc | David A. Lamond | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 May 2023 | 27,000 | 27,000 | - | - | Stock Option (right to buy) | |
| Nuveen Municipal Credit In... | David J. Lamb | Vice President | Purchase of securities on an exchange or from another person at price $ 11.66 per share. | 24 Feb 2023 | 6,000 | 6,000 (0%) | 0% | 11.7 | 69,960 | Common Stock |
| Distribution Solutions Gro... | David S. Lambert | VP, Controller and CAO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Jan 2023 | 20,035 | 20,035 | - | - | Stock Options | |
| Distribution Solutions Gro... | David S. Lambert | VP, Controller and CAO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Jan 2023 | 19,142 | 19,142 | - | - | Stock Options | |
| Riverview Bancorp, Inc. | David Lam | EVP/CFO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Jul 2022 | 5,793 | 52,943 (0%) | 0% | 0 | Common Stock | |
| Riverview Bancorp, Inc. | David Lam | EVP/CFO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Jul 2022 | 1,931 | 47,150 (0%) | 0% | 0 | Common Stock | |
| Distribution Solutions Gro... | David S. Lambert | VP, Controller and CAO | 15 Jun 2022 | 1,000 | 0 | - | - | Restricted Stock Units | ||
| Distribution Solutions Gro... | David S. Lambert | VP, Controller and CAO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 49.50 per share. | 15 Jun 2022 | 1,000 | 1,000 (0%) | 0% | 49.5 | 49,500 | Common Stock |
| Distribution Solutions Gro... | David S. Lambert | VP, Controller and CAO | Sale or transfer of securities back to the company at price $ 49.50 per share. | 15 Jun 2022 | 345 | 655 (0%) | 0% | 49.5 | 17,078 | Common Stock |
| Quince Therapeutics Inc | David A. Lamond | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Jun 2022 | 27,000 | 27,000 | - | - | Stock Option (right to buy) | |
| Applied Molecular Transpor... | David A. Lamond | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 May 2022 | 20,000 | 20,000 | - | - | Stock Option (Right to Buy) | |
| Applied Molecular Transpor... | David A. Lamond | Director | Purchase of securities on an exchange or from another person at price $ 3.26 per share. | 20 May 2022 | 33,500 | 1,077,519 | - | 3.3 | 109,210 | Common Stock |
| Applied Molecular Transpor... | David A. Lamond | Director | Purchase of securities on an exchange or from another person at price $ 3.08 per share. | 20 May 2022 | 33,000 | 1,044,019 | - | 3.1 | 101,640 | Common Stock |
| Quince Therapeutics Inc | David A. Lamond | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 May 2022 | 200,002 | 1,734,722 (5%) | 0% | - | Common Stock | |
| CVR Energy Inc | David L. Lamp | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 14 Dec 2021 | 13,217 | 13,217 (0%) | 0% | 0 | Common Stock | |
| CVR Energy Inc | David L. Lamp | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 14 Dec 2021 | 13,217 | 0 | - | - | Incentive Units | |
| CVR Energy Inc | David L. Lamp | Director, President and CEO | Sale or transfer of securities back to the company at price $ 16.07 per share. | 14 Dec 2021 | 13,217 | 0 (0%) | 0% | 16.1 | 212,397 | Common Stock |
| CVR Energy Inc | David L. Lamp | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Dec 2021 | 72,533 | 72,533 | - | - | Incentive Units | |
| CVR Energy Inc | David L. Lamp | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 08 Dec 2021 | 44,723 | 44,723 (0%) | 0% | 0 | Common Stock | |
| CVR Energy Inc | David L. Lamp | Director, President and CEO | Sale or transfer of securities back to the company at price $ 16.24 per share. | 08 Dec 2021 | 44,723 | 0 (0%) | 0% | 16.2 | 726,302 | Common Stock |
| CVR Energy Inc | David L. Lamp | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 08 Dec 2021 | 44,723 | 89,445 | - | - | Incentive Units | |
| CVR Energy Inc | David L. Lamp | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 08 Dec 2021 | 10,912 | 10,912 (0%) | 0% | 0 | Common Stock | |
| CVR Energy Inc | David L. Lamp | Director, President and CEO | Sale or transfer of securities back to the company at price $ 16.24 per share. | 08 Dec 2021 | 10,912 | 0 (0%) | 0% | 16.2 | 177,211 | Common Stock |
| CVR Energy Inc | David L. Lamp | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 08 Dec 2021 | 10,912 | 10,912 | - | - | Incentive Units | |
| Riverview Bancorp, Inc. | David Lam | EVP/CFO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Jul 2021 | 5,042 | 42,570 (0%) | 0% | 0 | Common Stock | |
| Riverview Bancorp, Inc. | David Lam | EVP/CFO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Jul 2021 | 1,681 | 37,528 (0%) | 0% | 0 | Common Stock | |
| Quince Therapeutics Inc | David A. Lamond | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Jun 2021 | 11,029 | 11,029 | - | - | Stock Option (right to buy) | |
| Distribution Solutions Gro... | David S. Lambert | VP, Controller and CAO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Jun 2021 | 1,000 | 1,000 | - | - | Restricted Stock Units | |
| Distribution Solutions Gro... | David S. Lambert | VP, Controller and CAO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Jun 2021 | 1,000 | 1,000 | - | - | Restricted Stock Units | |
| Distribution Solutions Gro... | David S. Lambert | VP, Controller and CAO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Jun 2021 | 708 | 708 | - | - | Market Stock Units | |
| Distribution Solutions Gro... | David S. Lambert | VP, Controller and CAO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Jun 2021 | 598 | 598 | - | - | Performance Awards | |
| Distribution Solutions Gro... | David S. Lambert | VP, Controller and CAO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Jun 2021 | 299 | 299 | - | - | Restricted Stock Units | |
| Applied Molecular Transpor... | David A. Lamond | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 May 2021 | 15,175 | 15,175 | - | - | Stock Option (Right to Buy) | |
| Applied Molecular Transpor... | David A. Lamond | Director | Purchase of securities on an exchange or from another person at price $ 42.00 per share. | 06 Apr 2021 | 25,000 | 1,011,019 | - | 42 | 1,050,000 | Common Stock |
| Quince Therapeutics Inc | David A. Lamond | Director | Purchase of securities on an exchange or from another person at price $ 33.77 per share. | 24 Mar 2021 | 50,000 | 1,847,109 (6%) | 0% | 33.8 | 1,688,500 | Common Stock |
| Quince Therapeutics Inc | David A. Lamond | Director | Gift of securities by or to the insider at price $ 0.00 per share. | 04 Mar 2021 | 1,534,720 | 1,534,720 (5%) | 5% | 0 | Common Stock | |
| Quince Therapeutics Inc | David A. Lamond | Director | Purchase of securities on an exchange or from another person at price $ 34.28 per share. | 04 Mar 2021 | 16,621 | 1,763,730 (6%) | 0% | 34.3 | 569,768 | Common Stock |
| Quince Therapeutics Inc | David A. Lamond | Director | Purchase of securities on an exchange or from another person at price $ 36.34 per share. | 04 Mar 2021 | 15,969 | 1,793,009 (6%) | 0% | 36.3 | 580,313 | Common Stock |
| Quince Therapeutics Inc | David A. Lamond | Director | Purchase of securities on an exchange or from another person at price $ 35.00 per share. | 04 Mar 2021 | 13,310 | 1,777,040 (6%) | 0% | 35 | 465,850 | Common Stock |
| Quince Therapeutics Inc | David A. Lamond | Director | Purchase of securities on an exchange or from another person at price $ 36.86 per share. | 04 Mar 2021 | 4,100 | 1,797,109 (6%) | 0% | 36.9 | 151,126 | Common Stock |
| CVR Energy Inc | David L. Lamp | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 14 Dec 2020 | 13,217 | 13,217 | - | - | Incentive Units | |
| CVR Energy Inc | David L. Lamp | Director, President and CEO | Sale or transfer of securities back to the company at price $ 15.55 per share. | 14 Dec 2020 | 13,217 | 0 (0%) | 0% | 15.5 | 205,524 | Common Stock |
| CVR Energy Inc | David L. Lamp | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 14 Dec 2020 | 13,217 | 13,217 (0%) | 0% | 0 | Common Stock | |
| CVR Energy Inc | David L. Lamp | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Dec 2020 | 134,168 | 134,168 | - | - | Incentive Units | |
| CVR Energy Inc | David L. Lamp | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 09 Dec 2020 | 10,913 | 10,913 (0%) | 0% | 0 | Common Stock | |
| CVR Energy Inc | David L. Lamp | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 09 Dec 2020 | 10,913 | 21,824 | - | - | Incentive Units |